Computational Drug Development Strategies to Target HIV-1
A New Applications in Drug Discovery
978-3-659-32753-7
3659327530
244
2013-01-18
79,00 €
eng
https://images.our-assets.com/cover/230x230/9783659327537.jpg
https://images.our-assets.com/fullcover/230x230/9783659327537.jpg
https://images.our-assets.com/cover/2000x/9783659327537.jpg
https://images.our-assets.com/fullcover/2000x/9783659327537.jpg
In the battle between human antiretroviral drug therapy techniques and HIV-1 microevolution, HIV-1 is currently outpacing human antiretroviral drug therapy techniques: all treatments ultimately end in HIV-1 developing resistance to the treatment. Some scientists believe humans are pushing the microevolution of HIV-1 toward more resistant viruses. For example, some researchers claim that human drug therapies are accelerating retrovirus evolution through drug therapies that select for resistant viruses. Human intervention on HIV-1 evolution through drug therapies has also been accused of being detrimental to the ultimate goal of finding a permanent cure for HIV-1.
https://morebooks.shop/books/de/published_by/lap-lambert-academic-publishing/47/products
Biochemie, Biophysik
https://morebooks.shop/store/de/book/computational-drug-development-strategies-to-target-hiv-1/isbn/978-3-659-32753-7